I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study
This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …
cisplatin
antiretroviral therapy
egfr exon 19 deletion
monoclonal antibody therapy
stage iia lung squamous cell carcinoma ajcc v7
- 0 views
- 19 Feb, 2024